SIP-AND-PUFF ASSISTIVE DEVICE SALES BUSINESS PLAN

I. Executive Summary

Company Description

Our company, BreatheBridge, takes its name from bridging breath and digital access to restore independence for people with severe motor impairments. Based in Austin, Texas, we operate in the biomedical assistive-technology sector, manufacturing high-precision, breath-controlled input devices for the 2026 U.S. market. Our core products are calibrated sip-and-puff interfaces and modular controllers that translate subtle respiratory signals into digital commands. These devices combine medical-grade sensors, low-latency firmware, and clinician-tuned profiles to deliver sub-100ms response and configurable sensitivity, making them competitive for both home users and institutional deployments.

We produce devices in an ISO-certified facility and back hardware with a high-touch clinical support model that includes training, device profiling, and remote firmware updates. We invested $125,000 in quality-assurance lab equipment and maintain a dedicated team of specialists to ensure reliability and regulatory readiness. Our target market spans individual end users, rehabilitation clinics, and large government purchasers such as the Department of Veterans Affairs. Short-term goals: complete CE/US regulatory checks and win pilot contracts with three VA sites by Q4 2026. Long-term goals: reach 5,000 active users and embed into standard clinical procurement lists within five years.

Problem

Individuals with severe motor impairments—including quadriplegia, ALS, and multiple sclerosis—cannot reliably use mainstream touchscreens and standard input devices, which blocks independent access to social, communication, and work activities.

Existing assistive technologies lack the precision and responsiveness needed for complex computer tasks, often require caregiver assistance, and leave a gap for low-effort, high-fidelity input systems tailored to this population.

Based in Austin, Texas, we manufacture high-precision, breath-controlled input devices in an ISO-certified facility and back them with clinical support and $125,000 invested in quality-assurance equipment to close this accessibility gap.

One-line summary: People with limited limb mobility need precise, low-effort input tools to regain digital independence.

Solution

Problem: Millions of people with conditions such as quadriplegia and ALS face digital isolation because existing interfaces lack the sensitivity and mobility needed for modern computing, limiting employment, social connection, and independent health management.

Solution: We offer a plug-and-play breath-input system—two hardware models, a high-precision flagship and a compact mobile device—that translates sips and puffs into precise cursor movement, clicks, keystrokes, and shortcuts across Windows, macOS, iOS, and Android, restoring full computer control for daily tasks.

Mission Statement

Our mission is to empower individuals with severe physical disabilities by providing the most precise, intuitive breath-operated technology that restores digital autonomy and expands access to communication, employment, and connection.

We deliver innovation, ergonomic design, and unwavering clinical support to enhance quality of life and serve as the gold standard in assistive technology for users and their healthcare providers.

Key Success Factors

Five clear advantages that will drive adoption, revenue, and long-term sustainability.

• Proprietary sensor technology delivers precision superior to existing market alternatives.
• First-mover position (2026) targets the mobile-specific assistive device market with a forecast of 2,000 units in year one.
• Institutional partnerships with the VA and rehabilitation centers provide a stable, scalable sales channel.
• High-touch onboarding and support ensures high user adoption and drives recurring accessory sales.
• Robust financials with a 157.68% IRR and immediate breakeven secure long-term sustainability.

Financial Summary

Concise financial snapshot for the Executive Summary showing revenue, profitability, and investor returns for the launch phase.

Financial requirements: minimum cash of $1,113,000 required (minimum cash month: Jan-26); total planned CAPEX $865,000 (listed items). The business reaches breakeven in Jan-26 and achieves a one-month payback; investors should expect the stated IRR 157.68% and ROE 69.09%.

Financial outlook: strong revenue growth, rising EBITDA, and exceptional investor returns through 2028.

Funding Requirements

We require USD 1,978,000 to secure the Austin facility, core hires, and the first production run.

Financial snapshot: 2026 revenue USD 7,725,000 growing to USD 36,735,000 by 2030; EBITDA USD 4,453,000 to USD 24,594,000; ROE 69.09%; IRR 157.68%; breakeven in month one; payback one month; total production 46,300 units by year five.